Private equity firms, known for their large-scale acquisitions in healthcare, have raised substantial funds. However, the impact of their involvement on patient outcomes remains unclear, with some evidence suggesting a decline in care quality. The influx of private equity into healthcare raises concerns about prioritizing financial gains over medical expertise.
Private equity firms acquire companies, known as platform companies, and expand them by acquiring smaller entities. They aim to grow these companies to a size that can be sold for a significant profit. This often involves substantial debt financing with high interest rates. While private equity firms typically assume ownership and control of the companies they acquire, their bankruptcy risk is transferred to the acquired companies.
Private equity’s involvement in healthcare has garnered attention due to the announcement of Drexel University eliminating 40% of its clinical staff following the impending closure of Hahnemann University Hospital. The hospital’s private equity owners had separated the real estate from the hospital, allowing them to declare bankruptcy without affecting the real estate assets. This incident highlights the potential for private equity firms to extract financial gains while compromising patient care and financial stability.